Gaza Cancer Care Crisis Deepens as Israeli Restrictions Raise Death Risk

GAZA CITY — The healthcare system in the Gaza Strip is confronting an unprecedented catastrophe, with thousands of cancer patients facing an imminent risk of death as severe medical shortages, destroyed oncology infrastructure, and stringent Israeli border restrictions completely sever access to life-saving treatment.

Before recent escalations, cancer was already one of the leading causes of mortality in Palestine. Today, oncology care inside Gaza has effectively ceased to exist. With the destruction and forced closure of specialized treatment centers, the blockading of essential chemotherapy and radiotherapy supplies, and tight restrictions on medical evacuations abroad, health authorities and international medical charities warn that preventable cancer deaths in the territory have soared.

Key Highlights of the Crisis

  • Triple Mortality Rate: Doctors and international humanitarian organizations report that cancer-related deaths in Gaza have doubled or tripled compared to pre-war baselines due to the total interruption of therapeutic protocols.
  • Destruction of Specialized Oncology Facilities: The Turkish-Palestinian Friendship Hospital—Gaza’s sole specialized facility for adult oncology—was forced to cease operations after sustaining severe damage, power cutoffs, and military incursions, leaving over 10,000 cancer patients without a dedicated treatment hub.
  • Blockade on Evacuations: Over 20,000 critically ill and injured patients, including more than 2,000 severe oncology cases, are currently denied permission or logistics to leave Gaza for urgent care in Egypt, the West Bank, East Jerusalem, or international facilities.
  • Total Absence of Advanced Therapies: Radiation therapy, nuclear scans, complex tumor resection surgeries, and key chemotherapy regimens are completely unavailable within the Strip due to import restrictions and infrastructural devastation.
  • Severe Vulnerability of Women and Children: Pediatric leukemia patients and women battling breast or cervical cancer face extreme mortality risks due to missing immune-boosting injections, delayed diagnostic testing, and the inability to travel with legal guardians.

The Complete Collapse of Gaza’s Specialized Oncology Sector

The delivery of cancer care requires a complex, multi-tiered medical ecosystem comprising precise diagnostic imaging, specialized pathology laboratories, sterile surgical environments, targeted radiotherapy apparatus, and a continuous pipeline of cytotoxic and hormonal pharmaceuticals. In Gaza, every pillar of this ecosystem has suffered systematic collapse.

Prior to the current crisis, the healthcare sector in Gaza was already severely constrained by years of economic isolation and restrictions on the import of advanced medical technology. Devices utilizing radioisotopes or specialized radiation technology were routinely classified under “dual-use” guidelines, preventing local hospitals from establishing full-scale radiotherapy suites. As a result, Gaza relied on a delicate balance: providing baseline chemotherapy locally at specialized centers while referring advanced cases to Palestinian facilities in East Jerusalem, the West Bank, or specialized centers in Jordan and Egypt.

Today, that fragile balance has dissolved. The sustained bombardment, heavy land operations, fuel cutoffs, and direct impacts on health facilities have rendered local treatment impossible while simultaneously sealing off external exit routes.

┌────────────────────────────────────────────────────────────────────────┐
│                   GAZA CANCER CARE SYSTEM: THEN VS. NOW                 │
├───────────────────────────┬────────────────────────────────────────────┤
│ Primary Oncology Hub      │ Destroyed / Forced Closure                 │
│ Radiation Therapy Access  │ 0% Available in Gaza (100% Relied on Exit) │
│ Chemotherapy Availability │ Severe Shortage / Total Depletion           │
│ Exit Permit Approvals     │ Reduced by Over 90%                        │
│ Mortality Trajectory      │ Estimated 2x to 3x Pre-War Baseline        │
└───────────────────────────┴────────────────────────────────────────────┘

Destruction of the Turkish-Palestinian Friendship Hospital

At the epicenter of Gaza’s cancer crisis is the fate of the Turkish-Palestinian Friendship Hospital. Funded by the Turkish government and opened to centralize oncology care, the 180-bed facility was the only government hospital in the Gaza Strip offering comprehensive diagnostic, surgical, and therapeutic services for adult cancer patients.

Within the initial weeks of military operations, the facility suffered severe damage, fuel exhaustion, and direct surrounding strikes, compelling management to evacuate patients and shut down operations. The shutdown forced hundreds of fragile patients undergoing active chemotherapy to suspend their cycles overnight. Subsequent military actions turned sections of the medical complex into military outposts, destroying specialized diagnostic laboratories, pharmacy stock rooms, and palliative care units.

Similarly, the oncology department at the Al-Rantisi Pediatric Hospital in Gaza City—which specialized in childhood cancers such as leukemia and lymphoma—was rendered entirely non-functional. Consequently, adult and pediatric oncology patients have been dispersed into overcrowded emergency shelters or primary clinics that lack even basic analgesics, let alone specialized cancer drugs.

The Exit Permit Standoff: Medical Evacuations Denied

For Gaza’s cancer patients, the inability to receive treatment locally makes medical evacuation a matter of immediate survival. However, border closures and tight security vetting procedures enforced by Israeli authorities have turned exit applications into a prolonged and often fatal ordeal.

The Erez and Rafah Crossing Blockades

Historically, patients seeking advanced care outside Gaza crossed through the Beit Hanoun (Erez) Crossing into Israel or the West Bank, or through the Rafah Crossing into Egypt. Following the closure and destruction of border infrastructure, international medical transfers plummeted.

According to human rights organizations and the Palestinian Ministry of Health:

  1. Permit Approval Rates Have Plummeted: Where thousands of patients previously traveled annually for oncology care, permit approvals have dropped by over 90%, leaving thousands of urgent permit applications lingering indefinitely “under study”.
  2. Security Vetting Delays: Patients and their designated companions—often mothers or spouses—are subjected to protracted background checks or mandatory security interviews. In hundreds of documented instances, approval arrives weeks or months after the patient has succumbed to their illness.
  3. Severe Backlog: Human rights organizations estimate that more than 20,000 individuals require urgent medical evacuation abroad, with over 2,000 experiencing life-threatening, advanced-stage cancer progression.

“Denying passage to patients in desperate need of medical care serves no legitimate security purpose. Patients are undergoing a slow, preventable death while awaiting approval for treatment that exists just miles away,” noted a legal researcher from the Palestinian Centre for Human Rights (PCHR).

Clinical Consequences: How Shortages Accelerate Mortality

In oncology, protocol continuity is critical. Missing a single scheduled dose of chemotherapy or delaying radiation cycles by a few weeks allows malignant cells to mutate, resist baseline medications, and metastasize rapidly.

                 ┌────────────────────────────────────────┐
                 │  THE CASCADE OF ONCOLOGICAL FAILURE    │
                 └───────────────────┬────────────────────┘
                                     │
        ┌────────────────────────────┼────────────────────────────┐
        ▼                            ▼                            ▼
┌──────────────────┐       ┌──────────────────┐       ┌──────────────────┐
│ 1. DRUG STOCKS   │       │ 2. PROTOCOL      │       │ 3. METASTASIS &  │
│    EXHAUSTED     │       │    INTERRUPTION  │       │    COMPLICATIONS │
│ Missing chemo,   │  ──►  │ Partial cycles   │  ──►  │ Unchecked tumor  │
│ hormonal drugs,  │       │ allow malignant  │       │ growth; fatal    │
│ & antibiotics    │       │ cell mutation    │       │ systemic failure │
└──────────────────┘       └──────────────────┘       └──────────────────┘

1. Depletion of Cytotoxic and Hormonal Medications

Hospital formularies across Gaza report zero stock for fundamental oncology medications, including Taxol, Herceptin, Glivec, and key hormonal agents. Without continuous administration, patients in remission face immediate relapse, while those with active tumors experience unchecked disease progression.

2. Lack of Supportive Care and Immune Boosters

Chemotherapy severely suppresses bone marrow function, leaving patients dangerously vulnerable to opportunistic bacterial and viral infections. Standard protocols require administering growth factor injections (such as Neupogen) post-treatment to boost white blood cell counts. The total absence of these supportive injections means that even minor systemic infections frequently prove fatal for Gazan cancer patients.

3. Diagnostic Blindness

Effective oncology management relies on periodic CT scans, MRI imaging, bone marrow biopsies, and specialized immunohistochemical staining to evaluate tumor response. With electrical grids destroyed, generator fuel severely restricted, and laboratory reagents exhausted, oncologists in Gaza are forced to practice in “diagnostic blindness,” unable to monitor whether a disease is spreading or responding to residual therapies.

Impact on Vulnerable Groups: Women and Children

The systemic collapse of cancer services has hit women and pediatric populations particularly hard.

Female Cancer Patients: Breast and Gynecological Cancers

Breast cancer accounts for the highest proportion of cancer diagnoses among women in Palestine. When detected early, localized breast cancer carries high survival rates through a combination of surgery, radiation, and targeted therapy. In Gaza, however, the lack of screening mammography combined with delayed referrals means women are overwhelmingly diagnosed at Stage III or Stage IV.

Furthermore, post-mastectomy radiation therapy is unavailable within the Gaza Strip. Without access to exit permits for radiation clinics in East Jerusalem or Egypt, surgical interventions often prove ineffective, leading to local recurrence and distant metastasis.

Pediatric Oncology: Children Left Without Care

Leukemia represents the most common pediatric cancer in Gaza. Pediatric protocols require precise, long-term chemo-regimens coupled with frequent lumbar punctures and blood transfusions.

Children face a dual hurdle: not only must their own medical eligibility be approved for travel, but their accompanying legal guardian must also clear security screening. Historically, over half of permit applications for pediatric companions were delayed or rejected, forcing young children to travel alone for treatment or remain in Gaza without care. Today, with medical evacuations virtually frozen, hundreds of children with treatable blood cancers are suffering terminal outcomes.

International Humanitarian Law and the Right to Health

Human rights organizations, legal experts, and UN agencies maintain that the systematic obstruction of medical care and border movement in Gaza violates established principles of international law.

The Fourth Geneva Convention

Under the Fourth Geneva Convention, an occupying or controlling power is obligated to ensure the civilian population has access to adequate medical care, food, and hygienic supplies. Article 56 specifically mandates that medical personnel and facilities must be protected and permitted to function without hindrance.

The Right to Life and Physical Integrity

Denying gravely ill civilians exit permits for essential medical procedures when local facilities cannot treat them constitutes a direct violation of the Right to Health and the Right to Life, as codified in the Universal Declaration of Human Rights and the International Covenant on Economic, Social and Cultural Rights (ICESCR). Legal bodies such as the International Court of Justice (ICJ) and the UN High Commissioner for Human Rights have repeatedly emphasized that restricting emergency medical access inflicts severe physical harm on vulnerable civilian populations.

Potential Pathways and International Demands

Reversing the trajectory of Gaza’s cancer care crisis requires immediate, coordinated international intervention across multiple fronts:

  1. Immediate Medical Evacuation Corridors: Establishing guaranteed, non-political medical transit routes through the Rafah and Erez crossings to transport critical oncology patients directly to specialized international hospitals.
  2. Protection and Rebuilding of Health Infrastructure: Rehabilitating key medical facilities, restoring dedicated power supply lines, and shipping fuel directly to hospital generators.
  3. Exemption of Essential Pharmaceuticals: Removing bureaucratic barriers on chemotherapy agents, diagnostic radioisotopes, laboratory reagents, and palliative pain medications entering the Strip.
  4. Deploying Field Oncology Units: Partnering with international humanitarian agencies (such as the WHO, ICRC, and MSF) to construct specialized field oncology clinics equipped with diagnostic imaging and chemotherapy suites directly inside Gaza.

Frequently Asked Questions (FAQ)

What was the main hospital treating cancer in Gaza before the war?

The Turkish-Palestinian Friendship Hospital was the primary public facility in the Gaza Strip providing specialized medical, diagnostic, and chemotherapy services for adult cancer patients.

Can cancer patients currently receive radiation therapy in Gaza?

No. Radiation therapy facilities do not exist in Gaza due to long-standing import restrictions on radioactive materials and dual-use medical technology. Historically, all patients requiring radiotherapy were referred to hospitals in East Jerusalem, the West Bank, or abroad.

How many cancer patients in Gaza are awaiting medical evacuation?

Crucial oncology medications and equipment face severe supply chain blockades, border crossing closures, destruction of pharmaceutical warehouses, and strict regulatory restrictions on imported medical items.

To gain a deeper visual understanding of how the destruction of healthcare infrastructure has impacted oncology treatment and patient mortality across the territory, watch this news report detailing the escalation of the crisis: Cancer deaths in Gaza triple as war cripples health system.

This video provides vital, on-the-ground reporting from medical staff and affected families in Gaza, clearly illustrating why doctors warn that cancer deaths have tripled as specialized oncology services collapse.

Read more fitness updates here

Leave a Reply

Your email address will not be published. Required fields are marked *